1,2-Diphenyl-3,5-dioxo-4-(3-hydroxybutyl)pyrazolidine
|
Basic information |
| Metabolite name | 1,2-Diphenyl-3,5-dioxo-4-(3-hydroxybutyl)pyrazolidine |
 | HMDB0252620 |
 |
N/A |
 |
120741 |
| Synonyms | Gamma-Hydroxyphenylbutazone |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | 1,2-Diphenyl-3,5-dioxo-4-(3-hydroxybutyl)pyrazolidine |
| HMDB0252620 |
|
N/A |
|
120741 |
| Synonyms | Gamma-Hydroxyphenylbutazone |
| No. of studies | 1 |
|
Relationship between 1,2-Diphenyl-3,5-dioxo-4-(3-hydroxybutyl)pyrazolidine and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1135 | Type1 | PSD group vs. control group | Faece | Sprague-Dawley rat | Down |